InsideTracker, a pioneer in hyper-personalized preventive health intelligence, announced the launch of a reimagined AI platform purpose-built to make individualized, evidence-based health guidance accessible anywhere consumers engage with wellness services. A longtime leader in direct-to-consumer biomarker insights, InsideTracker is now refocusing on wellness businesses that want to deliver scientifically proven health benefits at scale.

Those businesses have become the new front door to healthcare, with millions of consumers trading conventional clinical care for modern wellness experiences. But as the McKinsey's Future of Wellness survey finds, that growing market is raising an important bar for companies: 76% of consumers now consider medical and scientific credibility to be a top decision-making factor in their wellness investments.

"The industry has reached a now-or-never moment where generic claims are no longer good enough," said Rony Sellam, CEO of InsideTracker. "Now that wellness is healthcare's new front door, companies need to meet a higher standard of proof, and we've stepped in to enable that. Our platform is a fully configurable solution for organizations that want to offer health intelligence that sets their brand apart, but lack the scientific resources, longitudinal data, or vertical expertise to build it internally."

Setting a New Standard for Consumer Health Experiences

InsideTracker's new platform, Terra^™, is the culmination of 15 years of innovation by experts in aging, genetics, and biometric data from MIT and Tufts, and is informed by 5+ years of B2B experience with blue-chip enterprises, including collegiate and professional sports organizations, the US military, and commercial gym and fitness studio chains. It can generate a nearly infinite range of evidence- and biology-based health recommendations, by referencing a proprietary database of over 10 billion data points and a knowledge base of 7,000+ curated clinical studies.

Backed by the meaningful results of a landmark 20,000-user PLOS study, the platform now enables wellness companies to move from transactional exchanges to sustained engagement with consumers seeking evidence-based health guidance. With its flexible design and scientific rigor, Terra promises to be a measurable, sustained advantage for businesses pursuing $12 trillion in global economic value that could be unlocked by evidence-based health interventions.

Meeting New Market Demands With Neurosymbolic AI

At the core of the new Terra platform is a sophisticated neurosymbolic AI engine, which combines the pattern-recognition power of neural networks with explicit, rule-based symbolic reasoning. This framework translates complex biological data into transparent, 1:1 health guidance grounded in science.

This hybrid AI system is designed for seamless interoperability, a pain point in traditional healthcare and wellness alike. It allows partners to ingest biomarker data from almost any source — including blood and physiologic data from major labs and activity trackers like Apple Health, Oura, Fitbit, and Garmin — and combine it with their own customer data to precisely tailor health guidance.

"We're not just expanding access to proven outcomes with this platform," said Renée Deehan, PhD, SVP of Science and AI at InsideTracker, "We're giving businesses a low-lift, fast-to-market way to meet demand for health guidance that's precisely personalized and prioritized based on biomarker and other health data. That's the new cost of loyalty in today's wellness market, and Terra is optimized to help partners meet that demand at speed and scale."